MoonLake Immunotherapeutics (MLTX) Financials

$38.47

south_east
-$1.27 (-3.2%)
Day's range
$38.07
Day's range
$40.75
$0.00001525879$0.00001525879-$50B-$50B-$100B-$100B-$150B-$150BEarning20202020202120212022202220232023202420243%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

MLTX Income statement / Annual

Last year (2024), MoonLake Immunotherapeutics's total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, MoonLake Immunotherapeutics's net income was -$120.68 B. See MoonLake Immunotherapeutics,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $13,158.00 $12,358.00 $4,971.00 $0.00
Gross Profit $0.00 -$13,158.00 -$12,358.00 -$4,971.00 $0.00
Gross Profit Ratio 0 0 0 0 0
Research and Development Expenses $111.39 M $31.79 M $42.05 M $35.52 M $0.00
General & Administrative Expenses $30.32 B $22.32 M $23.01 M $21.66 M $0.00
Selling & Marketing Expenses -$30.29 B $0.00 $0.00 $18.03 M $0.00
Selling, General & Administrative Expenses $30.32 M $22.32 M $23.01 M $18.05 M $105,755.00
Other Expenses $0.00 $0.00 $591,732.00 $0.00 $0.00
Operating Expenses $141.71 M $54.12 M $65.06 M $53.57 M $105,755.00
Cost And Expenses $0.00 $54.12 M $65.06 M $53.58 M $105,755.00
Interest Income $0.00 $0.00 $0.00 $0.00 $14,917.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $0.00 $13,158.00 $12,358.00 $4,971.00 $206,297.00
EBITDA -$119.58 M -$54.11 M -$65.05 M -$53.63 M -$90,838.00
EBITDA Ratio 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0
Total Other Income/Expenses Net $0.00 $10.14 M $591,732.00 $10.65 M $14,922.00
Income Before Tax -$120.96 M -$43.98 M -$64.47 M -$53.64 M -$90,838.00
Income Before Tax Ratio 0 0 0 0 0
Income Tax Expense $282,199.00 $94,388.00 $36,366.00 $4,755.00 -$206,297.00
Net Income -$120.68 B -$36.01 M -$64.51 M -$53.64 M -$90,838.00
Net Income Ratio 0 0 0 0 0
EPS -1919.51 -0.73 -2.2 -6.84 -0.0061
EPS Diluted -1919.51 -0.73 -2.2 -6.84 -0.0061
Weighted Average Shares Out $62.87 M $49.12 M $29.36 M $7.84 M $14.81 M
Weighted Average Shares Out Diluted $62.87 M $49.12 M $29.36 M $7.84 M $14.81 M
Link